PharmacyCodes



Cefmenoximum [INN-Latin] en es it fr

Cefmenoximum [INN-Latin] Brand names, Cefmenoximum [INN-Latin] Analogs

Cefmenoximum [INN-Latin] Brand Names Mixture

  • No information avaliable

Cefmenoximum [INN-Latin] Chemical_Formula

C16H17N9O5S3

Cefmenoximum [INN-Latin] RX_link

No information avaliable

Cefmenoximum [INN-Latin] fda sheet

Cefmenoximum [INN-Latin] msds (material safety sheet)

Cefmenoximum [INN-Latin] Synthesis Reference

No information avaliable

Cefmenoximum [INN-Latin] Molecular Weight

511.562 g/mol

Cefmenoximum [INN-Latin] Melting Point

No information avaliable

Cefmenoximum [INN-Latin] H2O Solubility

No information avaliable

Cefmenoximum [INN-Latin] State

Solid

Cefmenoximum [INN-Latin] LogP

-1.056

Cefmenoximum [INN-Latin] Dosage Forms

Solution for injection

Cefmenoximum [INN-Latin] Indication

Used to treat female gynecologic and obstetric infections caused by susceptible aerobic (including the gonococcus) and anaerobic bacteria.

Cefmenoximum [INN-Latin] Pharmacology

Cefmenoxime is a semisynthetic beta-lactam cephalosporin antibiotic with activity similar to that of cefotaxime. It has broad spectrum activity against Gram positive and Gram negative bacteria.

Cefmenoximum [INN-Latin] Absorption

Bioavailability is approximately 100% following intramuscular injection.

Cefmenoximum [INN-Latin] side effects and Toxicity

Information on cefmenoxime overdosage in humans is not available. However, with other b-lactam antibiotics, adverse effects following overdosage have included nausea, vomiting, epigastric distress, diarrhea, and convulsions.

Cefmenoximum [INN-Latin] Patient Information

No information avaliable

Cefmenoximum [INN-Latin] Organisms Affected

Enteric bacteria and other eubacteria